Ovelle creates ovary and egg cells from stem cells to support infertility research and treatment.
Ovelle has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
Ovelle is headquartered in Boston, United States.
Ovelle creates ovary and egg cells from stem cells to support infertility research and treatment.
Ovelle is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ovelle — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/ovelle. Accessed September 27, 2026.
VCBacked. (2026). Ovelle — Funding & Investors. Retrieved September 27, 2026, from https://www.vcbacked.co/company/ovelle
{{cite web |title=Ovelle — Funding & Investors |url=https://www.vcbacked.co/company/ovelle |website=VCBacked |access-date=September 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated